Associate Professor Philip Newland-Jones
University Hospital Southampton NHSFT / University of Southampton, Southampton
Philip Newland-Jones is a Consultant Pharmacist and Honorary Associate Professor in Diabetes and Endocrinology at the University of Southampton, faculty of medicine and is the Clinical Director of the Diabetes and Endocrine Service at University Hospitals Southampton NHS Foundation Trust. He is a member of the UKCPA Diabetes and Endocrinology Committee, the Joint British Diabetes Societies (JBDS-IP) Committee, and the Centre of Perioperative Care (CPOC) diabetes working group. He is also currently chair of the endocrine pharmacist working group for the Society for Endocrinology.
At a national level he is the lead pharmacist for NHS England Diabetes and Endocrinology Clinical Reference Group and has worked at committee level in multiple diabetes/Endocrine organisations over the past 15 years. He is also a external specialist advisor to NHSE and DHSC for diabetes, endocrine and obesity pharmacotherapy. In 2015 he was awarded the National Leadership in Pharmacy award by the Royal Pharmaceutical Society and in 2021 was voted as “diabetes healthcare professional of the year” at the QIC awards. In 2021 he was designated as a Fellow of the Royal Pharmaceutical Society.
Philip leads a large dynamic team and is responsible for the direction of inpatient and outpatient diabetes and endocrine care at University Hospital Southampton. He works in a Consultant Pharmacist role on a day to day basis reviewing inpatients and outpatients with diabetes, endocrine and obesity issues. His dedication to education ensures the rest of his time is taken up educating doctors, nurses, allied healthcare professionals and students within secondary care, primary care and university settings.
At a national level he is the lead pharmacist for NHS England Diabetes and Endocrinology Clinical Reference Group and has worked at committee level in multiple diabetes/Endocrine organisations over the past 15 years. He is also a external specialist advisor to NHSE and DHSC for diabetes, endocrine and obesity pharmacotherapy. In 2015 he was awarded the National Leadership in Pharmacy award by the Royal Pharmaceutical Society and in 2021 was voted as “diabetes healthcare professional of the year” at the QIC awards. In 2021 he was designated as a Fellow of the Royal Pharmaceutical Society.
Philip leads a large dynamic team and is responsible for the direction of inpatient and outpatient diabetes and endocrine care at University Hospital Southampton. He works in a Consultant Pharmacist role on a day to day basis reviewing inpatients and outpatients with diabetes, endocrine and obesity issues. His dedication to education ensures the rest of his time is taken up educating doctors, nurses, allied healthcare professionals and students within secondary care, primary care and university settings.
